These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
486 related articles for article (PubMed ID: 6439036)
1. Concomitant insulin and sulfonylurea therapy in patients with type II diabetes. Effects on glucoregulation and lipid metabolism. Osei K; O'Dorisio TM; Falko JM Am J Med; 1984 Dec; 77(6):1002-9. PubMed ID: 6439036 [TBL] [Abstract][Full Text] [Related]
2. Combination insulin/glyburide therapy in type II diabetes mellitus. Effects on lipoprotein metabolism and glucoregulation. Falko JM; Osei K Am J Med; 1985 Sep; 79(3B):92-101. PubMed ID: 3931467 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group. DeFronzo RA; Goodman AM N Engl J Med; 1995 Aug; 333(9):541-9. PubMed ID: 7623902 [TBL] [Abstract][Full Text] [Related]
4. Serum C-peptide levels determine glycemic responses in type II diabetic patients treated with combined insulin and sulfonylurea agent. Osei K; Falko JM Am J Med Sci; 1985 Apr; 289(4):148-53. PubMed ID: 3920907 [TBL] [Abstract][Full Text] [Related]
5. Lipid effects of glyburide/metformin tablets in patients with type 2 diabetes mellitus with poor glycemic control and dyslipidemia in an open-label extension study. Dailey GE; Mohideen P; Fiedorek FT Clin Ther; 2002 Sep; 24(9):1426-38. PubMed ID: 12380634 [TBL] [Abstract][Full Text] [Related]
6. Combined therapy for obese type 2 diabetes: suppertime mixed insulin with daytime sulfonylurea. Riddle M; Hart J; Bingham P; Garrison C; McDaniel P Am J Med Sci; 1992 Mar; 303(3):151-6. PubMed ID: 1595776 [TBL] [Abstract][Full Text] [Related]
7. Triple therapy with glimepiride in patients with type 2 diabetes mellitus inadequately controlled by metformin and a thiazolidinedione: results of a 30-week, randomized, double-blind, placebo-controlled, parallel-group study. Roberts VL; Stewart J; Issa M; Lake B; Melis R Clin Ther; 2005 Oct; 27(10):1535-47. PubMed ID: 16330290 [TBL] [Abstract][Full Text] [Related]
8. Treatment of type I diabetes with a combination of glyburide and insulin. Gums JG; Curry RW; Montes de Oca G; Skluth HA; Reynolds LR Ann Pharmacother; 1992 Jun; 26(6):757-62. PubMed ID: 1611155 [TBL] [Abstract][Full Text] [Related]
9. Effects of combined insulin-sulfonylurea therapy in type II patients. Lewitt MS; Yu VK; Rennie GC; Carter JN; Marel GM; Yue DK; Hooper MJ Diabetes Care; 1989 Jun; 12(6):379-83. PubMed ID: 2499443 [TBL] [Abstract][Full Text] [Related]
10. Addition of sulfonylurea to insulin treatment in poorly controlled type II diabetes. A double-blind, randomized clinical trial. Schade DS; Mitchell WJ; Griego G JAMA; 1987 May; 257(18):2441-5. PubMed ID: 3106656 [TBL] [Abstract][Full Text] [Related]
11. Glyburide or insulin for metabolic control in non-insulin-dependent diabetes mellitus. A randomized, double-blind study. Nathan DM; Roussell A; Godine JE Ann Intern Med; 1988 Mar; 108(3):334-40. PubMed ID: 3124685 [TBL] [Abstract][Full Text] [Related]
12. Pioglitazone hydrochloride in combination with sulfonylurea therapy improves glycemic control in patients with type 2 diabetes mellitus: a randomized, placebo-controlled study. Kipnes MS; Krosnick A; Rendell MS; Egan JW; Mathisen AL; Schneider RL Am J Med; 2001 Jul; 111(1):10-7. PubMed ID: 11448655 [TBL] [Abstract][Full Text] [Related]
13. Comparison of morning or bedtime insulin with and without glyburide in secondary sulfonylurea failure. Soneru IL; Agrawal L; Murphy JC; Lawrence AM; Abraira C Diabetes Care; 1993 Jun; 16(6):896-901. PubMed ID: 8325203 [TBL] [Abstract][Full Text] [Related]
14. A comparison of preconstituted, fixed combinations of low-dose glyburide plus metformin versus high-dose glyburide alone in the treatment of type 2 diabetic patients. Erle G; Lovise S; Stocchiero C; Lora L; Coppini A; Marchetti P; Merante D Acta Diabetol; 1999 Jun; 36(1-2):61-5. PubMed ID: 10436254 [TBL] [Abstract][Full Text] [Related]
15. Glycemic control with Humalog Mix25 in type 2 diabetes inadequately controlled with glyburide. Roach ; Koledova E; Metcalfe S; Hultman C; Milicevic Z; Clin Ther; 2001 Oct; 23(10):1732-44. PubMed ID: 11726007 [TBL] [Abstract][Full Text] [Related]
16. Comparative efficacy of preprandial or postprandial Humalog Mix75/25 versus glyburide in patients 60 to 80 years of age with type 2 diabetes mellitus. Herz M; Sun B; Milicevic Z; Erickson P; Fövènyi J; Grzywa M; Pelikanova T Clin Ther; 2002 Jan; 24(1):73-86. PubMed ID: 11833837 [TBL] [Abstract][Full Text] [Related]
17. Comparison of insulin with or without continuation of oral hypoglycemic agents in the treatment of secondary failure in NIDDM patients. Chow CC; Tsang LW; Sorensen JP; Cockram CS Diabetes Care; 1995 Mar; 18(3):307-14. PubMed ID: 7555472 [TBL] [Abstract][Full Text] [Related]
18. Comparison of bedtime insulin regimens in patients with type 2 diabetes mellitus. A randomized, controlled trial. Yki-Järvinen H; Ryysy L; Nikkilä K; Tulokas T; Vanamo R; Heikkilä M Ann Intern Med; 1999 Mar; 130(5):389-96. PubMed ID: 10068412 [TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of normalizing fasting glucose with bedtime NPH insulin alone in NIDDM. Cusi K; Cunningham GR; Comstock JP Diabetes Care; 1995 Jun; 18(6):843-51. PubMed ID: 7555511 [TBL] [Abstract][Full Text] [Related]
20. Combination of insulin with glipizide increases peripheral glucose disposal in secondary failure type 2 diabetic patients. Simpson HC; Sturley R; Stirling CA; Reckless JP Diabet Med; 1990 Feb; 7(2):143-7. PubMed ID: 2137755 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]